Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pathologic and Protective Roles for Microglial Subsets and Bone Marrow- and Blood-Derived Myeloid Cells in Central Nervous System Inflammation.
Multiple sclerosis.
Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.
Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).
RAR-related orphan receptor A (RORA): A new susceptibility gene for multiple sclerosis.
Is involvement of inflammation underestimated in Pelizaeus-Merzbacher disease?
Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation.
Immunology of neuromyelitis optica during pregnancy.
Histological Basis of Laminar MRI Patterns in High Resolution Images of Fixed Human Auditory Cortex.
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.
Multi-Parametric Non-Negative Matrix Factorization for Longitudinal Variations Detection in White Matter Fiber-Bundles.
When Evaluating a New Thyroid Mass and a Ring-Enhancing Brain Lesion (When Two Presentations Collide).
Hospitalization, Inpatient burden and comorbidities associated with bullous pemphigoid in the United States.
Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.
Recurrent myelopathy and optic neuritis associated with systemic lupus erythematosus.
Ontogeny of Tissue-Resident Macrophages.
Neuroimmunology of a natural disaster.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Evolving Concepts in Posterior Subthalamic Area Deep Brain Stimulation for Treatment of Tremor: Surgical Neuroanatomy and Practical Considerations.
Gait Profile Score in multiple sclerosis patients with low disability.
Moringin activates Wnt canonical pathway by inhibiting GSK3β in a mouse model of experimental autoimmune encephalomyelitis.
Drugs for multiple sclerosis.
Movement-to-music (m2m) As An Alternative Form Of Exercise Rehabilitation For An Individual With Multiple Sclerosis: 1568 Board #221 June 2, 8: 00 AM - 9: 30 AM.
Interferons and inflammasomes: Cooperation and counterregulation in disease.
Pages
« first
‹ previous
…
808
809
810
811
812
813
814
815
816
…
next ›
last »